Conavi Medical 주식 가격. CNVI - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

0.74

매수가

0.73

매도가

0.80

거래량

3,091

0.68 일간 변동폭 0.74

0.00 52주 범위 0.00

market_cap

84.39M

전일 종가

0.74

개장가

0.68

최근 거래 시간

0.75

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

발행 주식

114,040,000

배당수익률

주가수익률

12.13

주당순이익(EPS)

0.06

매출

17.63M

순이익

6.95M

섹터

Ortho,prosth,surg Appl,suply

산업

Business Services, Nec

본부

Toronto, Ontario, Can

설립됨

2008

Conavi Medical Corp is listed in the Ortho,prosth,surg Appl,suply sector of the TSX 벤처 거래소 with ticker CNVI. The last closing price for Conavi Medical was $0.74. Over the last year, Conavi Medical shares have traded in a share price range of $ 0.00 to $ 0.00.

Conavi Medical currently has 114,040,000 shares in issue. The market capitalisation of Conavi Medical is $84.39 million. Conavi Medical has a price to earnings ratio (PE ratio) of 12.13.

Conavi Medical Retains BND Projects Inc. for Corporate Development Services

TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Corporation”), a commercial stage medical device company focused on designing, manufacturing, and...

Conavi Medical Corp. Announces Proposed Public Offering of Units

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF...

Conavi Medical Provides Shareholder Update and 2025 Outlook

- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...

Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing...

Conavi Medical Announces Grant of Stock Options

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock...

Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights

– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...

Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference

– Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast presentation on Wednesday, December 11ᵗʰ at 3:35 p.m. ET – TORONTO, Dec. 10, 2024 (GLOBE...

China's NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the promissory note owed by it to EOM – – Conavi Medical eligible to...

JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies

– Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries – – Company showcasing its...

Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services

TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- CONAVI MEDICAL CORP. (TSXV: CNVI) (“CONAVI MEDICAL” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing...

Conavi Medical Retains BND Projects Inc. for Corporate Development Services

Conavi Medical Corp. Announces Proposed Public Offering of Units

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF...

Conavi Medical Provides Shareholder Update and 2025 Outlook

- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...

Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing...

Conavi Medical Announces Grant of Stock Options

Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights

– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...

Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference

China's NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP

– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the promissory note owed by it to EOM – – Conavi Medical eligible to...

JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies

Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services

Conavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”

TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“Conavi” or the “Company”) (TSXV: CNVI) is pleased to announce that, pursuant to its press...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CNVI - Frequently Asked Questions (FAQ)

What is the current Conavi Medical share price?

The current share price of Conavi Medical is $ 0.74

How many Conavi Medical shares are in issue?

Conavi Medical has 114,040,000 shares in issue

What is the market cap of Conavi Medical?

The market capitalisation of Conavi Medical is CAD 84.39M

What is the 1 year trading range for Conavi Medical share price?

Conavi Medical has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Conavi Medical?

The price to earnings ratio of Conavi Medical is 12.13

What is the cash to sales ratio of Conavi Medical?

The cash to sales ratio of Conavi Medical is 4.79

What is the reporting currency for Conavi Medical?

Conavi Medical reports financial results in USD

What is the latest annual turnover for Conavi Medical?

The latest annual turnover of Conavi Medical is USD 17.63M

What is the latest annual profit for Conavi Medical?

The latest annual profit of Conavi Medical is USD 6.95M

What is the registered address of Conavi Medical?

The registered address for Conavi Medical is 293, LESMILL ROAD, TORONTO, ONTARIO, M3B 2V1

Which industry sector does Conavi Medical operate in?

Conavi Medical operates in the BUSINESS SERVICES, NEC sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ADG.HArcus Development Group Inc	$ 0.025 (400.00%)	260.5k
CEN.HClaren Energy Corp	$ 0.155 (342.86%)	25k
SGUSignature Resources Ltd	$ 0.06 (100.00%)	1.2M
BOCABocana Resources Corp	$ 0.01 (100.00%)	64k
CPICarlton Precious Inc	$ 0.09 (80.00%)	34.5k
RGIReco International Group Inc	$ 0.01 (-50.00%)	28k
CNST.PConstellation Capital Corp	$ 0.04 (-42.86%)	20k
GAR.HGreen Arrow Resources Inc	$ 0.025 (-37.50%)	2k
CBLUClear Blue Technologies International Inc	$ 0.02 (-33.33%)	11k
MTLOMartello Technologies Group Inc	$ 0.01 (-33.33%)	4.74k
LUCALuca Mining Corp	$ 1.02 (5.15%)	7.95M
OMIOrosur Mining Inc	$ 0.245 (44.12%)	2.57M
AGAGArgenta Silver Corp	$ 0.26 (6.12%)	2.32M
SXLSlam Exploration Ltd	$ 0.025 (25.00%)	1.88M
CHSComprehensive Healthcare Systems Inc	$ 0.01 (0.00%)	1.87M